Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (53)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Liu, J.
Right arrow Articles by Waalkes, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, J.
Right arrow Articles by Waalkes, M. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 55, 460-467 (2000)
Copyright © 2000 by the Society of Toxicology

Metallothionein-I/II Null Mice Are More Sensitive than Wild-Type Mice to the Hepatotoxic and Nephrotoxic Effects of Chronic Oral or Injected Inorganic Arsenicals

Jie Liu*, Yaping Liu{dagger}, Robert A. Goyer{ddagger}, William Achanzar* and Michael P. Waalkes*,1

* Laboratory of Comparative Carcinogenesis, NCI at NIEHS, Mail Drop F0-09, Research Triangle Park, North Carolina 27709; {dagger} University of Kansas Medical Center, Kansas City, Kansas; and {ddagger} Office of the Director, NIEHS, Research Triangle Park, North Carolina

Metallothionein (MT) is a low-molecular-weight, sulfhydryl-rich, metal-binding protein that can protect against the toxicity of cadmium, mercury, and copper. However, the role of MT in arsenic (As)-induced toxicity is less certain. To better define the ability of MT to modify As toxicity, MT-I/II knockout (MT-null) mice and the corresponding wild-type mice (WT) were exposed to arsenite [As(III)] or arsenate [As(V)] either through the drinking water for 48 weeks, or through repeated sc injections (5 days/week) for 15 weeks. Chronic As exposure increased tissue MT concentrations (2–5-fold) in the WT but not in MT-null mice. Arsenic by both routes produced damage to the liver (fatty infiltration, inflammation, and focal necrosis) and kidney (tubular cell vacuolization, inflammatory cell infiltration, and interstitial fibrosis) in both MT-null and WT mice. However, in MT-null mice, the pathological lesions were more frequent and severe when compared to WT mice. This was confirmed biochemically, in that, at the higher oral doses of As, blood urea nitrogen (BUN) levels were increased more in MT-null mice (60%) than in WT mice (30%). Chronic As exposures produced 2–10 fold elevation of serum interleukin-1ß, interleukin-6, and tumor necrosis factor-{alpha} levels, with greater increases seen by repeated injections than by oral exposure, and again, MT-null mice had higher serum cytokines than WT mice after As exposure. Repeated As injections also decreased hepatic glutathione (GSH) by 35%, but GSH-peroxidase and GSH-reductase were minimally affected. MT-null mice were more sensitive than WT mice to the effect of GSH depletion by As(V). Hepatic caspase-3 activity was increased (2–3-fold) in both WT and MT-null mice, indicative of apoptotic cell death. In summary, chronic inorganic As exposure produced injuries to multiple organs, and MT-null mice are generally more susceptible than WT mice to As-induced toxicity regardless of route of exposure, suggesting that MT could be a cellular factor in protecting against chronic As toxicity.

Key Words: arsenite; arsenate; chronic exposures; metallothionein-I/II null mice; nephrotoxicity; serum cytokines; hepatotoxicity; glutathione.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
J. Wu, J. Liu, M. P. Waalkes, M.-L. Cheng, L. Li, C.-X. Li, and Q. Yang
High Dietary Fat Exacerbates Arsenic-Induced Liver Fibrosis in Mice
Experimental Biology and Medicine, March 1, 2008; 233(3): 377 - 384.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. S. Andrew, V. Bernardo, L. A. Warnke, J. C. Davey, T. Hampton, R. A. Mason, J. E. Thorpe, M. A. Ihnat, and J. W. Hamilton
Exposure to Arsenic at Levels Found in U.S. Drinking Water Modifies Expression in the Mouse Lung
Toxicol. Sci., November 1, 2007; 100(1): 75 - 87.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Kimura, Y. Ishida, T. Hayashi, T. Wada, H. Yokoyama, T. Sugaya, N. Mukaida, and T. Kondo
Interferon-{gamma} Plays Protective Roles in Sodium Arsenite-Induced Renal Injury by Up-Regulating Intrarenal Multidrug Resistance-Associated Protein 1 Expression
Am. J. Pathol., October 1, 2006; 169(4): 1118 - 1128.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Chen, S. Li, J. Liu, B. A. Diwan, J. C. Barrett, and M. P. Waalkes
Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis
Carcinogenesis, September 1, 2004; 25(9): 1779 - 1786.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
R. N. Pires Das Neves, F. Carvalho, M. Carvalho, E. Fernandes, E. Soares, M. D. L. Bastos, and M. D. L. Pereira
Protective Activity of Hesperidin and Lipoic Acid Against Sodium Arsenite Acute Toxicity in Mice
Toxicol Pathol, August 1, 2004; 32(5): 527 - 535.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
J. Shen, H. Wanibuchi, E. I. Salim, M. Wei, A. Kinoshita, K. Yoshida, G. Endo, and S. Fukushima
Liver tumorigenicity of trimethylarsine oxide in male Fischer 344 rats--association with oxidative DNA damage and enhanced cell proliferation
Carcinogenesis, November 1, 2003; 24(11): 1827 - 1835.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. Schuliga, S. Chouchane, and E. T. Snow
Upregulation of Glutathione-Related Genes and Enzyme Activities in Cultured Human Cells by Sublethal Concentrations of Inorganic Arsenic
Toxicol. Sci., December 1, 2002; 70(2): 183 - 192.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
D.-S. Bae, C. Gennings, W. H. Carter Jr., R. S. H. Yang, and J. A. Campain
Toxicological Interactions among Arsenic, Cadmium, Chromium, and Lead in Human Keratinocytes
Toxicol. Sci., September 1, 2001; 63(1): 132 - 142.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Liu, H. Chen, D. S. Miller, J. E. Saavedra, L. K. Keefer, D. R. Johnson, C. D. Klaassen, and M. P. Waalkes
Overexpression of Glutathione S-Transferase II and Multidrug Resistance Transport Proteins Is Associated with Acquired Tolerance to Inorganic Arsenic
Mol. Pharmacol., August 1, 2001; 60(2): 302 - 309.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. Liu, M. B. Kadiiska, Y. Liu, T. Lu, W. Qu, and M. P. Waalkes
Stress-Related Gene Expression in Mice Treated with Inorganic Arsenicals
Toxicol. Sci., June 1, 2001; 61(2): 314 - 320.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
T. Lu, J. Liu, E. L. LeCluyse, Y.-S. Zhou, M.-L. Cheng, and M. P. Waalkes
Application of cDNA Microarray to the Study of Arsenic-Induced Liver Diseases in the Population of Guizhou, China
Toxicol. Sci., January 1, 2001; 59(1): 185 - 192.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.